Literature DB >> 2336770

Extracorporeal shock-wave lithotripsy in horseshoe kidneys.

D R Locke1, R C Newman, G S Steinbock, B Finlayson.   

Abstract

Using the Dornier HM-3 lithotriptor, 10 patients (11 renal units) with calculi in horseshoe kidneys were treated with extracorporeal shock-wave lithotripsy (ESWL) and ancillary procedures. Six renal units (55%) underwent pre-ESWL manipulation consisting of a Double J stent, ureteral catheter, or percutaneous nephrostomy. The "blast path" was employed to treat five renal units which could not be positioned at F2. Good initial stone fragmentation was obtained in eight renal units (73%). There were two episodes of post-ESWL obstruction requiring intervention; both occurred in the same patient. A total of seven post-ESWL procedures were performed on two renal units. After all procedures, eight renal units (73%) were rendered stone-free, six (55%) with ESWL alone. The average follow-up interval was twelve months (range 1-28 months). ESWL can be used effectively to treat some patients with calculi in horseshoe kidneys. The ectopic location of these renal units may make it difficult to position calculi at F2, thus necessitating treatment on the blast path or placement of the patient in prone position. Multiple ancillary procedures may be necessary.

Entities:  

Mesh:

Year:  1990        PMID: 2336770     DOI: 10.1016/0090-4295(90)80082-x

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  3 in total

1.  Treatment of calculi in kidneys with congenital anomalies: an assessment of the efficacy of lithotripsy.

Authors:  Adel R Al-Tawheed; Khaleel A Al-Awadi; Elijah O Kehinde; Hamdy Abdul-Halim; Akram M Hanafi; Yusuf Ali
Journal:  Urol Res       Date:  2006-06-29

Review 2.  Recent advances in lithotripsy technology and treatment strategies: A systematic review update.

Authors:  H E Elmansy; J E Lingeman
Journal:  Int J Surg       Date:  2016-11-24       Impact factor: 6.071

3.  Retrograde transureteral approach: a safe and efficient treatment for recurrent cystine renal stones.

Authors:  Lorenzo Ruggera; Martina Zanin; Paolo Beltrami; Filiberto Zattoni
Journal:  Urol Res       Date:  2010-12-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.